Filing Details
- Accession Number:
- 0001225208-18-009816
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-24 14:56:08
- Reporting Period:
- 2018-05-22
- Accepted Time:
- 2018-05-24 14:56:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1666700 | Dowdupont Inc. | DWDP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1308007 | J Charles Kalil | C/O The Dow Chemical Company 2030 Dow Center Midland MI 48674 | Special Counsellor | No | Yes | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-22 | 91,035 | $32.16 | 397,884 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-05-22 | 38,813 | $34.00 | 436,697 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-22 | 38,813 | $68.43 | 397,884 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-22 | 91,035 | $68.41 | 306,849 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2018-05-22 | 38,813 | $0.00 | 38,813 | $34.00 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2018-05-22 | 91,035 | $0.00 | 91,035 | $32.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,231 | 2022-02-10 | No | 4 | M | Direct | |
| 110,255 | 2023-02-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,086 | Indirect | By 401(k) Plan |
| Common Stock | 4,361 | Indirect | By 401(k) Plan ESOP |
Footnotes
- The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The price represents the weighted average sale price. All sales occurred at a range of $68.30 to $68.66.
- The price represents the weighted average sale price. All sales occurred at a range of $68.30 to $68.72.
- Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights.
- The options vested in three annual installments beginning on February 10, 2013.
- The options vested in three annual installments beginning on February 15, 2014.
Billionaire Hedge Funds
